Protocol SHP647-301: A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects with Moderate to Severe Ulcerative Colitis (FIGARO UC 301)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/12/19 → 6/12/22

Funding

  • PPD Investigator Services, LLC (Protocol SHP647-301)
  • Shire Human Genetic Therapies, Inc. (Protocol SHP647-301)